Sign up to save your podcasts
Or
Share Consolidative Immunotherapy in Unresectable Stage III NSCLC With Oncogenic Drivers
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Consolidative Immunotherapy in Unresectable Stage III NSCLC With Oncogenic Drivers
Host: Joshua E. Reuss, MD
In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.
View all episodes
Host: Joshua E. Reuss, MD
In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.